Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis

被引：8
|
作者：
Christopeit, M. [1 ]
Badbaran, A. [1 ]
Zabelina, T. [1 ]
Zeck, G. [1 ]
Fehse, B. [1 ]
Ayuk, F. [1 ]
Wolschke, C. [1 ]
Kroeger, N. [1 ]
机构：
[1] Univ Med Ctr Hamburg, Dept Stem Cell Transplantat, Hamburg, Germany
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷 / 10期
关键词：
MYELOPROLIFERATIVE NEOPLASMS; COMPETING RISK; PROGNOSTIC IMPACT; CALR MUTATIONS; JAK2; CLINICIAN; 1-LIKE; GUIDE; MPL;
D O I：
10.1038/bmt.2016.128
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1391 / 1393
页数：3
相关论文
共 50 条
  • [41] Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis
    Nagi, W.
    Lim, Z. Y.
    Krishnamurthy, P.
    Potter, V.
    Tindell, V.
    Reiff-Zall, L.
    Abdullah, A.
    Lea, N.
    Kenyon, M.
    Marsh, J.
    Ho, A. Y. L.
    Mufti, G. J.
    Pagliuca, A.
    LEUKEMIA RESEARCH, 2011, 35 (08) : 998 - 1000
  • [42] Allogeneic haematopoietic stem cell transplantation in patient with primary myelofibrosis and splanchnic vein thrombosis
    Barabanshikova, Maria
    Morozova, Elena
    Vlasova, Julia
    Moiseev, Ivan
    Pirogova, Olga
    Baikov, Vadim
    Shvetsov, Alexander
    Smirnov, Alexander
    Darskaya, Elena
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2019, 54 : 208 - 208
  • [43] Allogeneic haematopoietic stem cell transplantation in children with acute myeloid leukemia: RIC versus MAC
    Razumova, S. V.
    Bondarenko, S.
    Stancheva, N.
    Semenova, E.
    Alyanskiy, A.
    Fedukova, Y.
    Paina, O.
    Borovkova, A.
    Kozhokar, P.
    Zubarovskaya, L.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S442 - S443
  • [44] Outcome Improvement After Allogeneic Stem-Cell Transplantation in Myelofibrosis
    Kroeger, Nicolaus
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (07) : 629 - +
  • [45] The outcome of allogeneic hematopoietic stem cell transplantation for patients with primary myelofibrosis
    Sun, K.
    Tsai, X. C. -H.
    Liu, J. -H.
    Hsu, S. -C.
    Chou, W. -C.
    Liao, X. -W.
    Hou, H. -A.
    Ko, B. -S.
    Tien, H. -F.
    Tang, J. -L.
    Yao, M.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 161 - 161
  • [46] Favourable outcome of allogeneic haematopoietic stem cell transplantation (HSCT) for patients with myelofibrosis in non-advanced disease stages
    Ditschkowski, M
    Elmaagacli, AH
    Trenschel, R
    Hlinka, M
    Peceny, R
    Koldehoff, M
    Beelen, DW
    BONE MARROW TRANSPLANTATION, 2005, 35 : S69 - S69
  • [47] Lung function screening following allogeneic haematopoietic stem cell transplantation
    Wright, C.
    Krishnamurthy, P.
    Sander, C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 289 - 290
  • [48] Bilateral loss of vision following allogeneic haematopoietic stem cell transplantation
    Tumino, M.
    Fantinato, M.
    Winzler, C.
    Manara, R.
    Zannin, M. E.
    Emanuelli, E.
    Calore, E.
    Pillon, M.
    Buldini, B.
    Putti, M. C.
    Messina, C.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S231 - S232
  • [49] Secondary breast cancer following allogeneic haematopoietic stem cell transplantation
    Rovó, A
    Friedman, DL
    Socié, G
    Tichelli, A
    Deeg, HJ
    Leisenrin, W
    BONE MARROW TRANSPLANTATION, 2006, 37 : S39 - S39
  • [50] Cerebral toxoplasmosis following allogeneic haematopoietic stem-cell transplantation
    Ozkan, H.
    Hakko, E.
    Karaman, K.
    Ozer, U.
    Gulbas, Z.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S329 - S330
12345